Harout Semerjian
Algemeen Directeur bij GLYCOMIMETICS, INC.
Vermogen: 42 750 $ op 30-04-2024
Actieve functies van Harout Semerjian
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| GLYCOMIMETICS, INC. | Directeur/Bestuurslid | 06-08-2021 | - |
| Algemeen Directeur | 06-08-2021 | - | |
| President | 06-08-2021 | - |
Loopbaan van Harout Semerjian
Eerdere bekende functies van Harout Semerjian
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| IMMUNOMEDICS, INC. | Directeur/Bestuurslid | 16-04-2020 | 27-05-2020 |
| Algemeen Directeur | 16-04-2020 | 27-05-2020 | |
| President | 16-04-2020 | 27-05-2020 | |
| IPSEN | Corporate Officer/Principal | 01-03-2018 | 01-04-2020 |
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Corporate Officer/Principal | - | - |
Opleiding van Harout Semerjian
| Cornell University | Masters Business Admin |
| Queen's University | Masters Business Admin |
| Lebanese American University | Undergraduate Degree |
Statistieken
Internationaal
| Frankrijk | 3 |
| Verenigde Staten | 3 |
| Canada | 2 |
Operationeel
| Corporate Officer/Principal | 2 |
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| IPSEN | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Health Technology |
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
| GlycoMimetics, Inc. |
- Beurs
- Insiders
- Harout Semerjian
- Ervaring